Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Neuphoria Therapeutics Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Neuphoria Therapeutics is a clinical-stage biopharmaceutical company developing novel treatments for neuropsychiatric disorders. The company focuses on innovative therapies for conditions such as depression, anxiety, and other mental health disorders using proprietary drug candidates and delivery mechanisms.